Additionally, knockdown of PCGEM1 inhibits NSCLC cell invasion and migration by sponging miR-152-3p, indicating PCGEM1/miR-152-3p axis may be novel therapeutic targets for NSCLC treatment (54). Here, PCGEM1 is linked to non-small cell lung carcinoma.